Cite
HARVARD Citation
Losurdo, G. et al. (n.d.). Rifabutin‐based 10‐day and 14‐day triple therapy as a third‐line and fourth‐line regimen for Helicobacter pylori eradication: how should rifabutin be managed in rescue regimens?. United European Gastroenterology journal. 4 (3), pp. 474-475. [Online].